Nasdaq Stock Market · REGN

Regeneron Pharmaceuticals, Inc. price

Price history, key statistics, and comparable assets for Regeneron Pharmaceuticals, Inc..

$784.36

+1.59% ($12.25)

USD cached quoteYahoo Finance

Historical prices

Price history

Intraday through long-term closing prices. Choose 1 day, 1 week, 1 month, 6 months, year to date, 1 year, 5 years, or all available history.

Price chart range

1Y daily closing price

$784.36

Up +40.08% over 1Y

Range low
$542.96
Range high
$810.08

Use the left and right arrow keys to inspect prices. On a touch screen, tap the chart to inspect the nearest point.

1Y daily closing-price chart, up 40.08 percent

Aug 8, 2025Aug 7, 2026

Point-in-time fields

Key statistics

Previous close
$772.11
Open
$774.47
Day range
$767.82 to $785.98
52-week range
$541.00 to $821.11
Volume
837.6K
Average volume
900.74K
Market cap
80.75B
P/E ratio (TTM)
19.38

Profile

About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. trades on Nasdaq Stock Market under REGN and is grouped under Health Technology. Figures marked unavailable are not estimated.

Contextual peers

REGN questions

Regeneron Pharmaceuticals, Inc. questions

What is the REGN stock price?

Regeneron Pharmaceuticals, Inc. (REGN) had a cached quote of $784.36 as of 2026-08-07T20:00:01.000Z. Market prices move, so this is not an execution quote.

Where does Glide get REGN stock data?

Glide uses Yahoo Finance market data. Quotes and daily history are cached with the original market timestamp, and visiting this page does not contact Yahoo Finance.

Can I access REGN through Glide?

Glide does not list a tokenized REGN product in its current asset registry. This market-data page does not imply that the stock is tradeable on Glide.

Risk and data disclosure

Read before using this data

Glide provides this market data for informational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any asset. Prices may be delayed or incomplete. Verify market data and consider your objectives, financial situation, and professional advice before acting.

View Yahoo Finance source record